References
- Ekström M, Allingham SF, Eagar K, Yates P, Johnson C, Currow DC. Breathlessness during the last week of life in palliative care: an Australian prospective, longitudinal study. J Pain Symptom Manage 2016;51:816–23. doi: 10.1016/j.jpainsymman.2015.12.311
- Maeda T, Hayakawa T. Combined effect of opioids and corticosteroids for alleviating dyspnea in terminal cancer patients: a retrospective review. J Pain Palliat Care Pharmacother 2016;30:106–10. doi: 10.3109/15360288.2016.1167803
- Miura T, Matsumoto Y, Motonaga S, Hasuo H, Abe K, Kinoshita H. Dyspnea, relative youth and low daily doses of opioids predict increased opioid dosage in the last week of a terminal cancer patient's life. Jpn J Clin Oncol 2014;44:1082–7. doi: 10.1093/jjco/hyu137
- Gamborg H, Riis J, Christrup L, Krantz T. Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases. J Opioid Manag 2013;9:269–74.
- Tiep B, Carter R, Zachariah F, Williams AC, Horak D, Barnett M, et al. Oxygen for end-of-life lung cancer care: managing dyspnea and hypoxemia. Expert Rev Respir Med 2013;7:479–90. doi: 10.1586/17476348.2013.816565
- Ben-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer SM. Interventions for alleviating cancer-related dyspnea: a systematic review and meta-analysis. Acta Oncol 2012;51:996–1008. doi: 10.3109/0284186X.2012.709638
- Miyashita M, Matoba K, Sasahara T, Kizawa Y, Maruguchi M, Abe M, et al. Reliability and validity of the Japanese version of the Support Team Assessment Schedule (STAS-J). Palliat Support Care 2004;2:379–85. doi: 10.1017/S1478951504040507
- Matsuo N, Morita T, Iwase S. Efficacy and undesirable effects of corticosteroid therapy experienced by palliative care specialists in Japan: a nationwide survey. J Palliat Med 2011;14:840–5. doi: 10.1089/jpm.2011.0002
- Gripp S, Moeller S, Bölke E, Schmitt G, Matuschek C, Asgari S, et al. Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol 2007;25:3313–20. doi: 10.1200/JCO.2006.10.5411
- Vigano A, Donaldson N, Higginson IJ, Bruera E, Mahmud S, Suarez-Almazor M. Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer 2004;101:1090–8. doi: 10.1002/cncr.20472
- Maltoni M, Pirovano M, Scarpi E, Marinari M, Indelli M, Arnoldi E, et al. Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study. Cancer 1995;75:2613–22. doi: 10.1002/1097-0142(19950515)75:10<2613::AID-CNCR2820751032>3.0.CO;2-1
- Escalante CP, Martin CG, Elting LS, Cantor SB, Harle TS, Price KJ, et al. Dyspnea in cancer patients. Etiology, resource utilization, and survival-implications in a managed care world. Cancer 1996;78:1314–9. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1314::AID-CNCR21>3.0.CO;2-2